Background. Clostridioides difficile Infection (CDI) is a highly contagious bacterium that can be transferred from an infected surface. In this study, the Nationwide Readmissions Database was used to assess the risk of 30-, 60-, and 90-day readmissions in patients with comorbid CDI and renal failure (RF).
Background. Clostridium difficile infection (CDI) is now the most common pathogen causing nosocomial infectious diarrhea in the United States, and more than 500,000 people are estimated to have either healthcare-associated (HA) or community acquired (CA) CDI. The epidemiology of CDI is incompletely understood with more than 50% of all CDI cases occurring in the outpatient community and growing at a pace that is greater than HA-CDI.
Methods. Patients with CDI within Santa Barbara County, California were identified via three types of tests: Clostridium difficile PCR, gastrointestinal panel by PCR, and enzyme immunoassay (EIA) via local laboratory. Basic patient characteristics were analyzed using descriptive statistics. Changes with CA-CDI incidence were examined on a quarterly basis to identify and compare quarterly trends in CA-CDI incidence. Geographic Information Systems (GIS) mapping was utilized to provide better spatial understanding of disease distribution across communities.
Results. Over 2,000 unique patients with CDI were identified between January 1, 2013 and January 31, 2019. Median age of these patients was 64 years (interquartile range: 45 -78) and 60% were female. Hot spots of CDI within Santa Barbara County were localized to three major cities: Santa Barbara, Goleta, and Lompoc. Our results show that based on seasonal quarterly data CDI occurred most frequently in winter months.
Conclusion. In conclusion, CDI hot spots occurred most frequently during winter months and could possibly be associated with increased antibiotic treatment during flu season. Using the results from this study, we believe that by utilizing spatial and seasonal trends associated with CDI, physicians may be able to identify, diagnose and treat patients with CDI more promptly in Santa Barbara County.
Disclosures. Background. Children with sickle cell disease (SCD) have numerous risk factors for intestinal dysbiosis, including frequent hospitalization, iron overload, antibiotic exposure including penicillin prophylaxis, hypoxia, and altered gut permeability. Many of these conditions are also established risk factors for C. difficile infection (CDI); however, the incidence of CDI in children with SCD has not been characterized.
Methods. We performed a 10-year retrospective review from 1/2008-December 2017. Patients who qualified with CDI were either admitted or within 2 weeks of discharge from our site and had a positive test. A positive test was defined as a positive glutamate dehydrogenase 1 test in conjunction with either a positive ELISA or a positive PCR for toxin. Three investigators independently reviewed if patients had active diarrhea during the time of their positivity. Patients excluded were <2 years old and patients undergoing a stem cell transplant (SCT) or irritable bowel disease (IBD) at the time of a positive test. Chi-square test with Yates correction, descriptive statistics were used when comparing groups<./p> Results. Over a 10-year period (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) , there were 5666 admissions for children with SCD, corresponding to 25,915 hospitalization days and 957 unique patients. The average age of this cohort at the time of admission was 10.6 ± 6.7 years; 51.7% were male. One patient qualified; a 12-year-old who developed diarrhea and abdominal pain after recent hospitalization for pneumonia ( Figure 1 ). This yielded a CDI incidence of 0.39/10,000 patient-days or 0.18 cases per 1000 admissions (Table 1 ). There were 208 cases of CDI in non-SCD children, with an incidence of 5.53/10,000 patient-days (P < 0.001) or 2.77 cases per 1000 admissions (P < 0.001) (Table 2) during the study period. In 2015-2017, there were no cases of CDI in 957 SCD patients, of which 218 were on penicillin prophylaxis.
Conclusion. There is a very low incidence of CDI in children with SCD despite significant antibiotic exposure and other risk factors for intestinal dysbiosis. These findings are consistent with recent studies in adults (N Engl J Med 2019; 380:887-888) and suggest that sickle cell patients are somehow protected against CDI. Additional studies are needed to define the host and biome factors that confer this protection.
